HPV infection and the alterations of the pRB pathway in oral carcinogenesis

Oncology Reports

Volumn 17, Issue 6, 2007, Pages 1321-1326

  Lim, Kue Peng ^a   Hamid, Sharifah ^a   Lau, Shin Hin ^b   Teo, Soo Hwang ^a   Cheong, Sok Ching ^a  

^a CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^b INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

Human papillomavirus; Oral squamous cell carcinoma; Retinoblastoma pathway

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL TRANSFORMATION; EXON; FEMALE; GENE DELETION; GENETICS; HOMOZYGOTE; HUMAN; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; MALAYSIA; MALE; METABOLISM; MOUTH TUMOR; PAPILLOMA VIRUS; SQUAMOUS CELL CARCINOMA; VIROLOGY; VIRUS INFECTION;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EXONS; FEMALE; GENE DELETION; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MALAYSIA; MALE; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEINS;

EID: 34548016801     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.6.1321     Document Type: Article

References (30)

1. Lim GCC, Yahya H and Lim TO: The first report of the national cancer registry: cancer incidence in Malaysia. Kuala Lumpur, Ministry of Health, 2002.
2. Todd R, Hinds PW, Munger K, Rustgi AK, Opitz OG, Suliman Y and Wong DT: Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med 13: 51-61, 2002. (Pubitemid 34792760)
3. Pande P, Mathur M, Shukla NK and Ralhan R: pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncol 34: 396-403, 1998. (Pubitemid 28440304)
4. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y and Yamamuro T: Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54: 3042-3048, 1994. (Pubitemid 24187793)
5. Rocco JW and Sidransky D: p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 264: 42-55, 2001. (Pubitemid 32989080)
6. Nakahara Y, Shintani S, Mihara M, Kiyota A, Ueyama Y and Matsumura T: Alterations of Rb, p16(INK4A) and cyclin D1 in the tumorigenesis of oral squamous cell carcinomas. Cancer Lett 160: 3-8, 2000.
7. Callender T, El-Naggar AK, Lee MS, Frankenthaler R, Luna MA and Batsakis JG: PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74: 152-158, 1994. (Pubitemid 24187623)
8. Hunter T and Pines J: Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994. (Pubitemid 24363801)
9. Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR and Brakenhoff RH: Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96: 998-1006, 2004. (Pubitemid 39162642)
10. Rose BR, Li W and O'Brien CJ: Human papillomavirus: a cause of some head and neck cancers? Establishing a causal link between HPV and certain head and neck cancers would have implications for prognosis, prevention and therapy. Med J Aust 181: 415-416, 2004.
11. Piboonniyom SO, Duensing S, Swilling NW, Hasskarl J, Hinds PW and Munger K: Abrogation of the retinoblastoma tumor suppressor check-point during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability. Cancer Res 63: 476-483, 2003. (Pubitemid 36152510)
12. Syrjanen KJ: HPV infections and oesophageal cancer. J Clin Pathol 55: 721-728, 2002.
13. Gillison ML and Lowy DR: A causal role for human papilloma-virus in head and neck cancer. Lancet 363: 1488-1489, 2004.
14. Lim KP, Sharifah H, Lau SH, Teo SH and Cheong SC: Alterations of the p14ARF-p53-MDM2 pathway in oral squamous cell carcinoma: MDM2 overexpression is a common event. Oncol Rep 14: 963-968, 2005.
15. Lehmann U, Glockner S, Kleeberger W, von Wasielewski HF and Kreipe H: Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. Am J Pathol 156: 1855-1864, 2000. (Pubitemid 30641755)
16. De Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ and Snijders PJ: The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76: 1057-1062, 1995.
17. Farhadi M, Tahmasebi Z, Merat S, Kamangar F, Nasrollahzadeh D and Malekzadeh R: Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol 11: 1200-1203, 2005. (Pubitemid 40353009)
18. Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, Kumar S, Gopalkrishna V, Kumar N and Das BC: p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 218: 69-79, 2005. (Pubitemid 40082703)
19. Xing EP, Nie Y, Song Y, Yang GY, Cai YC, Wang LD and Yang CS: Mechanisms of inactivation of p14ARF, p15INK4b and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 5: 2704-2713, 1999. (Pubitemid 29493943)
20. Kresty LA, Mallery SR, Knobloch TJ, Song H, Lloyd M, Casto BC and Weghorst CM: Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res 62: 5295-5300, 2002. (Pubitemid 35024605)
21. Geradts J, Hu SX, Lincoln CE, Benedict WF and Xu HJ: Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int J Cancer 58: 161-167, 1994. (Pubitemid 24240089)
22. Nishimoto IN, Pinheiro NA, Rogatto SR, Carvalho AL, Simpson AJ, Caballero OL and Kowalski LP: Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in non-alcoholics. Oral Oncol 40: 604-610, 2004. (Pubitemid 38452680)
23. Zheng Y, Shen H, Sturgis EM, Wang LE, Eicher SA, Strom SS, Frazier ML, Spitz MR and Wei Q: Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis 22: 1195-1199, 2001. (Pubitemid 32737335)
24. Kalish LH, Kwong RA, Cole IE, Gallagher RM, Sutherland RL and Musgrove EA: Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines. Clin Cancer Res 10: 7764-7774, 2004. (Pubitemid 39557542)
25. Shapiro GI: Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 24: 1770-1783, 2006.
26. Yin C, Shen LJ, Xie SM, Ruan P and Yao X: Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions. Di Yi Jun Yi Da Xue Xue Bao 25: 812-814, 2005.
27. Syrjanen S: Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 32 (suppl 1): S59-S66, 2005.
28. Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU and Chan SY: Human papilloma-viruses in 91 oral cancers from Indian betel quid chewers-high prevalence and multiplicity of infections. Int J Cancer 61: 450-454, 1995.
29. Miguel RE, Villa LL, Cordeiro AC, Prado JC, Sobrinho JS and Kowalski LP: Low prevalence of human papillomavirus in a geographic region with a high incidence of head and neck cancer. Am J Surg 176: 428-429, 1998. (Pubitemid 29021541)
30. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernandez L, Idris A, Sanchez MJ, Nieto A, Talamini R, Tavani A, Bosch FX, Reidel U, Snijders PJ, Meijer CJ, Viscidi R, Munoz N and Franceschi S: Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95: 1772-1783, 2003. (Pubitemid 38008900)